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Abstract
Background: Perceptions of illness are important determinants of health behaviour. A better understanding of
perceptions of obesity might allow more effective interventions that challenge these perceptions through lifestyle
modification programs. Although several studies have evaluated causal attributions with regard to obesity, other
domains of illness perception, such as the perceived consequences of obesity and perceived controllability, have
not yet been studied. The aim of the current study was to explore perceptions regarding causes, consequences,
control, concerns and time course of obesity of centrally obese adults, with and without an elevated cardiometabolic
risk and with or without weight loss, 3 years after screening for metabolic syndrome, and to compare these
perceptions.
Methods: Three groups were selected from a longitudinal study dependent on the baseline and 3-year follow-up
profiles: individuals with central obesity and metabolic syndrome at both time points (‘persistent cardiometabolic-risk
group’, n = 80), those with central obesity but without metabolic syndrome on either occasion (‘persistent obese
group’, n = 63), and formerly obese individuals (‘improved cardiometabolic-risk group’, n = 49). Perceptions of obesity
were assessed using an adapted version of the Brief Illness Perception Questionnaire (BIPQ, range 0–10). Chi-square
and Kruskal-Wallis tests were performed to compare the ‘persistent cardiometabolic risk’ group with the other two
groups with regard to patient characteristics and BIPQ scores.
Results: Both males and females who improved their cardiometabolic risk perceived their obesity as shorter (median
(IQR): 3.0 (4.0) vs. 6.0 (3.0), p < 0.001) and experienced greater personal control over their weight (7.0 (3.0) vs. 5.0 (3.0),
p = 0.002) compared to those who did not improve. Females who improved their cardiometabolic risk experienced
fewer identity and illness concerns, this was not found for males. Other scores did not differ between groups.
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Conclusion: Obese adults with an improved cardiometabolic risk profile felt greater personal control and considered
their obesity to be of shorter duration. Persistence of central obesity with additional cardiometabolic risk factors had a
larger impact on female than male participants with respect to identity and illness concerns. Whether discussing
‘personal control’ is a favourable element in lifestyle intervention should now be assessed in the setting of a
controlled trial.
Keywords: Illness perceptions, Obesity, Prevention, Health behaviour, Cardiometabolic risk
Background
The prevalence of overweight and obesity is increasing.
In 2009/2010, more than half of all Dutch adults aged
30–70 had a body mass index (BMI) ≥25.0 kg/m2 and
13 % of men and 14 % of women were obese (BMI
≥30.0 kg/m2) [1]. Corresponding numbers in other Euro-
pean Union countries and the United States are even
higher [2, 3]. Due to the increasing prevalence of over-
weight and obesity, the number of people with hyperten-
sion, dyslipidaemia and an impaired glucose level is also
rising. This will lead to a further increase in cardiovascu-
lar disease and type 2 diabetes.
Lifestyle modifications leading to modest weight loss
can prevent cardiovascular disease (mainly due to the
positive effects of weight loss on blood pressure and
lipid profile) and diabetes [4–7]. However, changing
health-related behaviour remains a challenge as the effect-
iveness of interventions in routine clinical care, outside a
strictly controlled trial setting, has been disappointing or
cannot be maintained in the long term [8–12]. This may
be partly due to a sedentary lifestyle and an overabun-
dance of high calorie foods, but may also relate to an indi-
vidual’s perception of overweight and obesity. The Health
Belief Model postulates that people need to experience a
certain health threat before changing their behaviour [13].
Thus, people with overweight or obesity need to view their
condition as serious and they should be aware of the asso-
ciated health risks. In addition, overweight and obese
people must feel in control in order to manage their
weight, and they must believe that a specific behaviour
will lead to a certain health outcome and that they will be
able to adopt and maintain the desired behaviour – the
so-called self-efficacy belief [14]. Self-efficacy beliefs
significantly relate to a persons perceptions of control over
their illness [15].
These various perceptions are combined in the Com-
mon Sense Model [16]. According to this model, people
make sense of a health threat by developing their own
cognitive and emotional perceptions or representations
of that threat. These will determine how they cope with
their health condition.
A number of studies have evaluated causal attributions
with regard to obesity [17–20]. But other domains of ill-
ness perceptions, such as the perceived consequences of
overweight and obesity and their perceived controllabil-
ity, have not yet been studied. Likewise, it is not clear if
persons with central obesity with and without an ele-
vated cardiometabolic risk differ in their perceptions. It
is possible that individuals with central obesity and ele-
vated cardiometabolic risk factors attribute more symp-
toms to their overweight or obese condition, perceive
more negative consequences and express more concern
than persons with central obesity alone. Furthermore,
those who suffered from obesity in the past but suc-
ceeded in losing weight might experience more personal
control compared with people who failed to lose weight.
Understanding these issues might allow more effective
interventions to be developed that challenge these per-
ceptions through lifestyle modification programs. There-
fore, the aim of the current study was to explore the
perceptions of individuals with screening-detected cen-
tral obesity, with or without additional cardiometabolic
risk factors. More specifically, we compared the percep-
tions of those who remained stable with those who im-
proved their cardiometabolic risk profile during the
follow-up period.
Methods
Study design and participants
Participants were selected from a large study that was
designed to evaluate screening and follow-up in meta-
bolic syndrome (MetS). The study included 11,862 indi-
viduals aged 20–70 years who were not previously
diagnosed with diabetes, hypertension, dyslipidaemia or
cardiovascular disease [21–24]. Screening took place be-
tween September 2006 and May 2007. The first stage
was self-measurement of waist circumference with a
tape measure mailed to the patient’s home. The results
were sent to the research centre. A total of 1721 people
with self-detected central obesity (waist circumference
≥88 cm in women and ≥102 cm in men) underwent fur-
ther examinations at the research centre (waist circum-
ference was verified by the research team; measured in
duplicate, and the mean score of this was further used);
473 persons were diagnosed with MetS according to the
National Cholesterol Education Program’s Adult Treat-
ment Panel III (NCEP ATP III) [24, 25]. When cardio-
vascular risk factors were detected individuals were
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advised to contact their general practitioner (GP), advice
that was followed by 72 % (increasing to 90 % after a
reminder). No other intervention was performed [23].
All persons should have received usual care according to
the guidelines ‘Cardiovascular risk management’ and
‘Type 2 Diabetes Mellitus’ of the Dutch College of
General Practitioners [26, 27]. At follow-up, in Novem-
ber and December 2009, we compared perceptions with
regard to obesity in three groups with central obesity at
baseline (as determined by self-measured waist circum-
ference). The first group had central obesity and MetS,
both at baseline and at follow-up (the “persistent cardio-
metabolic risk group”). The second group was derived
from a group of participants with central obesity at base-
line and at follow-up but without MetS (the “persistent
obesity group”). The third group consisted of people
with central obesity and MetS at baseline, but no longer
suffering from central obesity at follow-up (the
“improved cardiometabolic risk group”). The study was
approved by the Medical Ethical committee of the
University Medical Center Utrecht.
Measurements
Body weight, height, waist circumference and blood pres-
sure were measured at the research centre, both at screen-
ing and follow-up. Venous blood samples were drawn
after an overnight fast to determine fasting blood glucose,
triglycerides and high-density lipoprotein (HDL) choles-
terol. A detailed description of these measurements has
been published previously [22, 24]. Data on prescribed car-
diovascular medication at the time of follow-up were col-
lected from the physician’s electronic medical records [23].
Illness perceptions
At follow-up, participants completed an adapted version
of the “Brief Illness Perception Questionnaire” (BIPQ
[28]; Dutch version by Kaptein). The BIPQ includes
eight items scored on an 11-point scale, ranging from 0
to 10 (Table 1). Five items assess cognitive illness repre-
sentations: consequences, timeline, identity, personal
control and treatment control. Two items assess emo-
tional representations: concern and emotions. One item
assesses coherence. A ninth open-ended response item
assesses the patients’ causal representation by asking the
patient to list in rank-order the three most important
causal factors underlying their condition. The BIPQ has
proven to be a reliable and valid measure of illness per-
ceptions in a variety of patient populations [28]. In our
adapted (not validated) version, we replaced the word
‘disease’ with the word ‘overweight’ in all items, similar
to disease-specific versions of the more extended IPQ-R
[http://www.uib.no/ipq].Furthermore, because obesity
might be considered more a risk factor than a disease,
we assumed that individuals might not fully understand
the coherence item, and that the item on treatment con-
trol might not be considered applicable by all respondents.
We therefore removed these two items. In place of these
we added two items to gain more insight into outcome
Table 1 Adapted version of the Brief Illness Perception Questionnaire (BIPQ)
Question Evaluated perception domain Implication of a higher score
1 How much does your overweight affect your life? Consequences: beliefs about the impact of the
condition on physical, social and psychological
well-being
Greater perceived influence of the
condition upon life
2 How long do you think your overweight will
continue?
Timeline: beliefs about the expected duration
of the condition
A stronger belief in a chronic time course
3 How much control do you feel you have over your
overweight?
Curability/controllability, personal control: beliefs
about whether the condition can be cured or
kept under control through self-management
behaviour
Greater perceived personal control over
the condition
4 How much do you think physical activity can help
to improve your overweight?
Curability/controllability, behavioural control:
beliefs about whether the condition can be cured
or kept under control through physical activity
Greater perceived control over the
condition by physical activity
5 How much do you experience symptoms from
your overweight?
Identity: beliefs about the condition’s label and
associated symptoms
The patient perceives more symptoms as
a result of the condition
6 How concerned are you about your overweight? Concern: evaluates to what extent concern is
experienced
Greater feelings of concern about the
condition
7 How much do you think a modification of your
diet pattern can help improving your overweight?
Curability/controllability, behavioural control:
beliefs about whether the condition can be
ured or kept under control through diet
Greater perceived control over the
condition by diet
8 How much does your overweight affect you
emotionally? (e.g. does it make you angry, scared,
upset or depressed?)
Emotional representations: beliefs about the
affective responses associated with the illness
A stronger emotional response to the
condition
9 Please list in rank-order the 3 most important
factors that you believe caused your overweight.
Causal attribution: beliefs about factors or
conditions to have caused the illness
den Engelsen et al. BMC Public Health  (2015) 15:1214 Page 3 of 9
expectations, one of which referred to perceived control
by physical activity and the second to perceived control by
means of diet (Table 1). Since the original BIPQ items do
not constitute one (or more) overarching scale(s), the
scores of the six BIPQ items we included could still be
compared with the scores from other patient populations.
Statistical analysis
To explore patient characteristics and illness perceptions
of the three study groups, we computed descriptive sta-
tistics. Categorical variables are reported as numbers
and percentages, continuous variables as means with
standard deviations or median with inter quartile range
(IQR) for non-normally distributed variables. Chi-square
tests and the Kruskal-Wallis test were performed to
compare the ‘persistent cardiometabolic risk’ group with
the other two groups with regard to patient characteris-
tics and BIPQ scores. A p-value < 0.05 was considered
significant.
To identify potential confounders of the association be-
tween cardiometabolic risk level and obesity perceptions,
we evaluated associations between socio-demographic
characteristics and the BIPQ score for each domain.
Socio-demographic characteristics that differed (p <0.05)
between groups and that also showed a significant associ-
ation with (at least one of) the perceptions of obesity,
were considered as potential confounders. For gender,
stratified analyses were performed.
Spearman correlation coefficients (r) were computed
to assess associations between the various illness percep-
tion domains within each of the three groups.
The open answers to question nine (the factors that
people believed to be important causes of their over-
weight) were classified into behavioural factors (diet and
physical activity), biological factors (e.g. genetics, hor-
mones), psychological factors (e.g. stress, depression)
and other factors. Differences in frequency of each of
these factors (lifestyle, biological, psychological or other)
between the groups were tested using Chi-square tests.
Analyses were performed using the Statistical Package
of Social Sciences (SPSS) version 20.0 (SPSS (IBM),
Chicago, IL, USA).
Results
A total of 406 of the 473 participants with screen-
detected MetS were eligible for follow-up measurements
(reasons for ineligibility were change of address or a
critical illness) and were invited to participate, of whom
194 agreed. For the purpose of this study, we selected
only those participants who continued to fulfil the cen-
tral obesity and MetS criteria at follow-up (persistent
cardiometabolic risk group; n = 80), and those who no
longer had central obesity (improved cardiometabolic
risk group; n = 49). In addition, 144 participants with
central obesity but no other MetS components at base-
line were invited for the follow-up examinations, of
whom 88 agreed to participate. Of these, 63 had main-
tained their centrally obese phenotype (the persistent
obesity group), of whom five (four females and one
male) had developed MetS during follow-up, although
none required antihypertensive, glucose lowering or lipid
lowering medication (persistent obesity group) (Table 2).
The ‘improved cardiometabolic risk’ group did not differ
significantly from the ‘persistent cardiometabolic risk’
group with regards to age, gender, education level and
ethnicity. Individuals in the latter group were signifi-
cantly older and more likely to be male compared with
the ‘persistent obesity’ group. Mean levels of BMI, blood
pressure, triglycerides and fasting glucose were all sig-
nificantly higher - or in case of HDL cholesterol, signifi-
cantly lower - in the ‘persistent cardiometabolic risk’
group compared to the ‘persistent obesity’ group at the
time of measurement of illness perceptions.
Difference in illness perceptions between groups
Compared to the ‘improved cardiometabolic risk’ group,
both the ‘persistent cardiometabolic risk’ and ‘persistent
obesity’ groups differed significantly with regard to ‘time-
line’; the latter two groups considered their condition to
have a more or less chronic time course (median (IQR):
3 (4) vs. 6 (3) and 7 (3), both <0.01), with mild to modest
consequences (median (IQR): 3 (4.5) vs.4 (3) and 4 (4),
p = 0.03). They experienced few symptoms due to their
overweight (median (IQR): 1 (4) vs. 3 (4.75) and 2.5
(4.25), both p = 0.03). In general, individuals in the ‘per-
sistent cardiometabolic risk’ and ‘persistent obesity’
group believed that physical activity and diet could have
a positive effect on their body weight (open-ended ques-
tion). Their score on perceived personal control, how-
ever, shows that they were not convinced that they could
influence their condition themselves, indicating relatively
low self-efficacy beliefs (median (IQR): 7 (3) vs. 5 (3) and
5 (2.25), both p < 0.01).
Stratification for gender did not influence these find-
ings. However, gender did have an effect on identity per-
ception and on illness concerns. In the ‘improved
cardiometabolic risk’ group only females showed fewer
identity and illness concerns than their counterparts in
the ‘persistent cardiometabolic risk’ group (Table 3).
Correlations of illness perceptions
In all three groups (Table 4), high correlations (r ≥ 0.62,
p < 0.001) were found for the consequences, identity and
concern items. Scores on the two behavioural control
items (diet and exercise) were also correlated. For the
‘persistent cardiometabolic risk’ and the ‘improved
cardiometabolic risk’ groups, but not the ‘persistent
obesity’ group, scores on the behavioural control items
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group (n = 49)
Persistent
cardiometabolic risk






group (n = 49)
Consequence 4.0 (3.0) 3.5 (3.5) 3.0 (5.0) 4.0 (4.25) 4.0 (4.0) 2.0 (4.5)
Timeline 6.0 (3.25) 6.5 (3.5) 4.0 (2.75)*** 7.0 (3.5) 7.0 (2.75) 1.0 (2.5)***




8.0 (4.0) 6.5 (5.5) 8.0 (3.0) 7.0 (2.0) 7.0 (3.0) 8.0 (3.0)
Identity 3.0 (4.0) 2.5 (3.25) 2.0 (4.0) 3.0 (5.0) 2.5 (5.0) 0.0 (1.5)**
Illness concern 4.0 (5.0) 3.5 (4.25) 5.0 (4.0) 4.0 (4.0) 4.0 (3.0) 2.0 (3.0)***
Behavioural
control - diet
8.0 (3.0) 8.0 (2.75) 7.0 (3.0) 7.0 (3.5) 7.0 (4.0) 8.0 (4.0)
Emotional
representation
2.0 (3.0) 2.5 (4.75) 2.0 (4.75) 3.0 (5.0) 3.5 (6.0) 2.0 (3.5)
Data are reported as median (inter quartile range), range 0–10
P-value for difference between persistent cardiometabolic risk and persistent obesity groups, unadjusted: *p < 0.05; **p < 0.01; ***p < 0.001
P-value for difference between persistent and improved cardiometabolic risk groups, unadjusted *p < 0.05; **p < 0.01; ***p < 0.001
Table 2 Characteristics of 3 study groups
Baseline 3 year follow-up
Persistent
cardiometabolic risk






group (n = 49)
Persistent
cardiometabolic risk






group (n = 49)







Age (years) 49.4 (9.6) 45.5 (9.2) 49.7 (10.9) 52.8 (10.0) 48.9 (9.2)** 53.2 (10.8)
BMI (kg/m2) 31.0 (3.6) 28.8 (3.3) 28.4 (2.1) 30.7 (3.7) 29.3 (3.4)** 25.9 (2.5)***
Waist circumference
(cm)
Men 112.8 (10) 106.5 (4) 105.5 (5) 109.3 (12.2) 109.1 (5.3) 99.1 (3.8)***
Women 101.8 (10) 95.3 (8) 92.0 (14) 98.9 (8.8) 95.2 (8.8) 82.0 (14.8)***
Blood pressure
(mmHg)
Systolic 145.9 (17.3) 119.9 (5.9) 145.8 (13.5) 137.9 (14.8) 122.3 (8.4)*** 133.6 (10.9)
Diastolic 89.6 (7.6) 75.5 (4.7) 88.4 (7.6) 83.9 (7.2) 75.6 (5.5)*** 80.9 (7.9)
Triglycerides
(mmol/L)
1.8 (6) 0.9 (0) 1.9 (1) 2.1 (0.9) 1.2 (0.5)*** 1.5 (1.0)***
HDL cholesterol
(mmol/L)
Men 1.0 (0.4) 1.3 (0.4) 1.5 (0.7) 1.1 (0.4) 1.2 (0.4) 1.2 (0.5)
Women 1.2 (0.3) 1.6 (0.5) 1.5 (0.6) 1.2 (0.2) 1.5 (0.5)*** 1.4 (0.6)**
Fasting glucose
(mmol/L)
5.2 (1.2) 4.8 (0.5) 4.9 (0.9) 5.5 (1.1) 5.0 (0.5)*** 5.0 (0.8)**
Data are reported as mean (standard deviation) for age, BMI and blood pressure, as median (inter quartile range) for waist circumference, triglycerides, HDL
cholesterol and fasting glucose or percentage
P-value for difference at 3 year follow-up between persistent cardiometabolic risk and persistent obesity groups: *p < 0.05; **p < 0.01; ***p < 0.001
P-value for difference at 3 year follow-up between persistent and improved cardiometabolic risk groups: *p < 0.05; **p < 0.01; ***p < 0.001
BMI body mass index, HDL cholesterol high-density lipoprotein cholesterol
den Engelsen et al. BMC Public Health  (2015) 15:1214 Page 5 of 9
significantly correlated with the personal control score.
For both the ‘persistent cardiometabolic risk’ and
‘persistent obesity’ groups, scores on the emotional
representation item correlated highly with scores on the
consequences, identity and concern items. For the ‘im-
proved cardiometabolic risk’ group, these correlations
were weaker (r ≤ 0.45) and not all were significant.
In both the ‘persistent cardiometabolic risk’ and ‘im-
proved cardiometabolic risk’ groups, individuals who
considered their condition to be more chronic had
significantly higher scores on the consequences, identity
and concern items; in the ‘persistent obesity’ group,
timeline scores did not correlate with scores on any of
the other items.
Causal factors for obesity
The majority of the participants identified lifestyle fac-
tors as the most important causal factors for their
(former) obesity, diet being more often mentioned than
physical activity. Although this percentage was highest
in the ‘improved cardiometabolic risk’ group, the differ-
ence compared to the other two groups was not signifi-
cant. In the ‘persistent cardiometabolic risk’ and
‘persistent obesity’ groups, about one in five participants
considered biological factors as contributors to their
central obesity, while 7–10 % mentioned psychological
factors (Table 5).
Discussion
The current study explored obesity-related perceptions
amongst adults with central obesity with or without
cardiometabolic risk factors, and amongst individuals
with former central obesity. We expected that the per-
sistency of central obesity, combined with the detection
of additional cardiometabolic risk factors 3 years previ-
ously, would have had an impact on people’s perceptions
of their obesity. However, we could not demonstrate that
the presence of additional cardiometabolic risk factors
Table 4 BIPQ scale correlations (r) in the 3 study groups











risk group (n = 80)
Consequence 0.29** 0.15 0.10 0.71** 0.68** 0.15 0.61**
Timeline 0.05 0.08 0.36** 0.36** 0.10 0.21
Personal control 0.23* −0.01 0.07 0.23* 0.02
Behavioural control –
physical activity
−0.03 0.14 0.43** −0.04
Identity 0.67** 0.21 0.58**
Illness concern 0.24* 0.51**
Behavioural control - diet 0.11
Persistent obesity group
(n = 63)
Consequence −0.07 −0.20 0.29* 0.62** 0.66** 0.35** 0.60**
Timeline −0.20 −0.04 −0.02 −0.10 −0.08 −0.01
Personal control 0.03 −0.19 −0.08 −0.01 −0.07
Behavioural control –
physical activity
0.32* 0.30* 0.55** 0.28*
Identity 0.67** 0.20 0.56**
Illness concern 0.34** 0.63**
Behavioural control - diet 0.52**
Improved cardiometabolic
risk group
Consequence 0.42** 0.33** 0.15 0.63** 0.75** 0.35* 0.36*
Timeline −0.18 −0.06 0.61** 0.61** −0.09 0.18
Personal control 0.50** 0.12 0.22* 0.32* 0.07
Behavioural control –
physical activity
0.07 0.32* 0.42** 0.09
Identity 0.62** 0.15 0.30*
Illness concern 0.20 0.45**
Behavioural control - diet 0.32*
Spearman correlation coefficients
*Correlation is significant at the 0.05 level (2-tailed)
**Correlation is significant at the 0.01 level (2-tailed)
den Engelsen et al. BMC Public Health  (2015) 15:1214 Page 6 of 9
goes together with the perception of obesity as a more
serious condition. The relatively low scores on the con-
sequences, identity and concern items indicate that nei-
ther group considered obesity to be very serious. While
the idea that diet and physical activity can have a posi-
tive influence on weight was widely accepted by partici-
pants, the moderate score on perceived personal control
suggests that obese individuals have little confidence in
their own ability to control their body weight. However,
both males and females with central obesity at baseli-
ne—the improved cardiometabolic risk group—scored
higher on the personal control item than those in the
‘persistent cardiometabolic risk’ group, indicating that
those individuals who succeed in losing weight experi-
ence more personal control than those who do not.
Persistence of central obesity with additional cardio-
metabolic risk factors had a greater impact on female
than on male participants. Women who improved their
cardiometabolic risk profile perceived their overweight
as less identity restricting and less alarming than women
without cardiometabolic improvements. These differ-
ences were not found for men.
Almost all participants acknowledged that lifestyle fac-
tors were important causes of their overweight or obes-
ity. No correlation was found in the persistent central
obesity group between behavioural control scores and
personal control scores. This suggests that those who fail
to lose body weight may believe that changing diet and
physical activity patterns can help to reduce weight, but
at the same time do not necessarily believe they can in-
fluence their own body weight. Those in the ‘persistent
obesity’ group were unlikely to have received regular
follow-up care by a practice nurse, dietician or GP be-
cause they did not show additional cardiometabolic risk
factors. This might explain why participants in this
group did not feel a high level of personal control over
their condition. However, the group with persistent cen-
tral obesity and additional risk factors also perceived low
‘personal control’, despite being advised to contact their
GP. These findings suggest that persons with central
obesity between the ages of 20 and 70 years, whether or
not they have additional cardiometabolic risk factors or
have consulted their GP in connection with this, would
receive greater benefit from support that enhanced their
self-efficacy beliefs than from more information about
the role of a healthy diet and physical activity.
Strengths and limitations
Because illness perceptions were determined only at
follow-up, we could not assess causal relations between
perceptions regarding obesity and past or present over-
weight/obesity. Perceptions might have been influenced
by follow-up counselling in both the ‘persistent cardio-
metabolic risk’ and the ‘improved cardiometabolic risk’
groups. Likewise, the ‘persistent obesity’ group consisted
predominantly of females and was 4 years younger on
average than the other groups, which might have influ-
enced results. This group may go on to develop features
of MetS at a later stage, as indicated by mean waist
circumference, systolic blood pressure, triglyceride and
glucose levels, all of which increased after follow-up (in
contrast to the other groups). During follow-up, five
(four females and one male) of the 63 persons with
persistent obesity did in fact develop MetS. In order to
compensate for a possible gender difference, we analysed
group illness perceptions separately for males and fe-
males. In addition, due to the relatively small group
sizes, we may lack power to demonstrate clinically rele-
vant differences in perceptions regarding obesity between
the ‘persistent obesity’ and the ‘persistent cardiometabolic
risk’ groups. Nevertheless, as an initial investigation, we
believe that this study has produced interesting findings
that deserve further examination in a larger study.
The final open answer BIPQ item assessed patients’
causal perceptions by asking them to list in rank-order
the three most important causal factors for their excess
Table 5 Causes of obesity, as mentioned by participants
Mentioned as reason (%)
Persistent cardiometabolic risk group N = 71 Persistent obesity group N = 59 Improved cardiometabolic risk group N = 42
Lifestyle 91.5 88.1 97.6
Diet a77.5 a83.1 a85.7
Physical activity a50.7 a44.1 a52.4
Lifestyle, not specified a7.0 a1.7 a9.5
Biological 16.9 27.1 11.9
Genetics a15.5 a15.3 a7.1
Other a1.4 a11.9 a4.8
Psychological 7.0 10.2 7.1
Other 23.9 20.3 14.3
aPercentages of participants within the causal factor for obesity
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body weight. Mentioning physical activity and diet as
treatment options in previous questions might have
biased the results in this section.
Comparison with existing literature
We compared the perceptions of (former) centrally
obese adults with the illness perceptions of adults with
type 2 diabetes [28], and adults with hypertension [29].
Compared with a group of New Zealand type 2 diabetes
patients (mean age 57.2 years, 52.9 % male) and a group
of Portuguese hypertension patients (mean age 62 years,
41 % male), both our ‘persistent cardiometabolic risk’
and ‘persistent obesity’ groups had lower scores on the
timeline, consequences, identity, and concern items;
thus, they perceived their condition to be less threaten-
ing compared with the diabetes and hypertension pa-
tients. People with diabetes and hypertension, however,
experienced more personal control over their condition.
This may be due to the fact that both diabetes and
hypertension can be controlled by medication.
Lifestyle factors were mentioned as important causal
influences by approximately 90 % of the participants
with persistent obesity both with and without additional
cardiometabolic risk factors, and by 98 % of the former
centrally obese adults, which is higher than any previ-
ously reported. Wang et al. studied a mixed sample of
lean, overweight and obese people and asked them to
what extent they believed either lifestyle factors or inher-
itance influenced obesity. Of the respondents, 72 % en-
dorsed the belief that lifestyle behaviours have ‘a lot’ to
do with causing obesity, whereas only 19 % indicated
that inheritance has ‘a lot’ to do with causing obesity
[20]. Hilbert et al. assessed causal attributions of obesity
in obese people presenting for genetic testing and coun-
selling. Sixty-one percent of the participating women
and 73 % of the men endorsed behavioural attributions,
whereas 86 % of women and 60 % of men endorsed
genetic/biological attributions [18]. In both of these
studies, however, answers regarding causal factors were
structured, whereas we used an open-ended question.
We suspect that our approach facilitates the expression
of more spontaneous and deeply-based perceptions.
Conclusion
Individuals with persistent central obesity, irrespective of
additional cardiometabolic risk factors, seem to under-
estimate the seriousness of their condition and experi-
ence relatively low levels of personal control. Persistence
of central obesity with additional cardiometabolic risk
factors had a greater impact on female than on male
participants. Women who improved their cardiometa-
bolic risk profile perceived their overweight as less
identity restricting and less alarming than women with-
out cardiometabolic improvements. These differences
were not found for men. Lifestyle interventions, espe-
cially for women with obesity - regardless of the pres-
ence of additional cardiometabolic risk factors - should
therefore focus on increasing awareness of the serious
implications of overweight or obesity, on boosting per-
sonal confidence in an ability to influence body weight
and on enhancing a sense of personal control. Whether
discussing ‘personal control’ is a favourable addition in a
lifestyle intervention should now be assessed in the set-
ting of a controlled trial.
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